Fig. 2From: Antitumor activity of the protein kinase inhibitor 1-(β-D-2′-deoxyribofuranosyl)-4,5,6,7-tetrabromo- 1H-benzimidazole in breast cancer cell linesThe morphology of breast cancer cells cultured for 48 h, inverted microscopy. Panel A Control cells. Panel B Cells treated with compound (10 μM)Back to article page